Our sponsors

Boston Scientific is a global medical technology leader dedicated to transforming lives through innovative, high-performance solutions that address unmet clinical needs. Within its neuromodulation portfolio, Boston Scientific’s Deep Brain Stimulation (DBS) business focuses on advancing care for people living with complex neurological movement disorders.

Boston Scientific DBS systems are designed to deliver precise, customizable therapy for conditions such as Parkinson’s disease, dystonia, and essential tremor. Built on a foundation of clinical evidence, engineering excellence, and patient-centered design, the company’s DBS technologies aim to improve symptom control while supporting quality of life.

Through close collaboration with clinicians, researchers, and healthcare systems worldwide, Boston Scientific continues to invest in next-generation DBS innovation, education, and long-term patient support. Guided by a commitment to meaningful innovation and responsible science, Boston Scientific DBS strives to expand access to life-changing neuromodulation therapy that can improve the quality of life for millions worldwide.

Pharmanovia was founded in 2013 and has grown from a family run business to a global specialty pharma business, with more than 20 brands in over 140 markets, operating across 10 offices with over 275 employees – and we continue to grow ethically and sustainably across our four key therapy areas; Neurology, Cardiovascular, Endocrinology and Oncology.